|
1
|
Dahlbäck B and Villoutreix BO: Molecular
recognition in the protein C anticoagulant pathway. J Thromb
Haemost. 1:1525–1534. 2003.
|
|
2
|
Li W, Zheng X, Gu J, Hunter J, Ferrell GL,
Lupu F, Esmon NL and Esmon CT: Overexpressing endothelial cell
protein C receptor alters the hemostatic balance and protects mice
from endotoxin. J Thromb Haemost. 3:1351–1359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taylor FB Jr, Peer GT, Lockhart MS,
Ferrell G and Esmon CT: Endothelial cell protein C receptor plays
an important role in protein C activation in vivo. Blood.
97:1685–1688. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fukudome K and Esmon CT: Identification,
cloning, and regulation of a novel endothelial cell protein
C/activated protein C receptor. J Biol Chem. 269:26486–26491.
1994.PubMed/NCBI
|
|
5
|
Xu J, Qu D, Esmon NL and Esmon CT:
Metalloproteolytic release of endothelial cell protein C receptor.
J Biol Chem. 275:6038–6044. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fukudome K, Kurosawa S, Stearns-Kurosawa
DJ, He X, Rezaie AR and Esmon CT: The endothelial cell protein C
receptor. Cell surface expression and direct ligand binding by the
soluble receptor. J Biol Chem. 271:17491–17498. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Menschikowski M, Hagelgans A, Eisenhofer G
and Siegert G: Regulation of endothelial protein C receptor
shedding by cytokines is mediated through differential activation
of MAP kinase signaling pathways. Exp Cell Res. 315:2673–2682.
2009. View Article : Google Scholar
|
|
8
|
Guitton C, Gérard N, Sébille V,
Bretonnière C, Zambon O, Villers D and Charreau B: Early rise in
circulating endothelial protein C receptor correlates with poor
outcome in severe sepsis. Intensive Care Med. 37:950–956. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esmon CT: Possible involvement of
cytokines in diffuse intravascular coagulation and thrombosis.
Baillieres Best Pract Res Clin Haematol. 12:343–359. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pintao MC, Roshani S, de Visser MC, Tieken
C, Tanck MW, Wichers IM, Meijers JC, Rosendaal FR, Middeldorp S and
Reitsma PH: High levels of protein C are determined by PROCR
haplotype 3. J Thromb Haemost. 9:969–976. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saposnik B, Reny JL, Gaussem P, Emmerich
J, Aiach M and Gandrille S: A haplotype of the EPCR gene is
associated with increased plasma levels of sEPCR and is a candidate
risk factor for thrombosis. Blood. 103:1311–1318. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qu D, Wang Y, Song Y, Esmon NL and Esmon
CT: The Ser219 −>Gly dimorphism of the endothelial protein C
receptor contributes to the higher soluble protein levels observed
in individuals with the A3 haplotype. J Thromb Haemost. 4:229–235.
2006.
|
|
13
|
Tsuneyoshi N, Fukudome K, Horiguchi S, Ye
X, Matsuzaki M, Toi M, Suzuki K and Kimoto M: Expression and
anticoagulant function of the endothelial cell protein C receptor
(EPCR) in cancer cell lines. Thromb Haemost. 85:356–361.
2001.PubMed/NCBI
|
|
14
|
Wang X, Wang E, Kavanagh JJ and Freedman
RS: Ovarian cancer, the coagulation pathway, and inflammation. J
Transl Med. 3:252005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Scheffer GL, Flens MJ, Hageman S,
Izquierdo MA, Shoemaker RH and Scheper RJ: Expression of the
vascular endothelial cell protein C receptor in epithelial
tumour cells. Eur J Cancer. 38:1535–1542. 2002.PubMed/NCBI
|
|
16
|
Beaulieu LM and Church FC: Activated
protein C promotes breast cancer cell migration through
interactions with EPCR and PAR-1. Exp Cell Res. 313:677–687. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ducros E, Berthaut A, Mirshahi SS, Faussat
AM, Soria J, Agarwal MK and Mirshahi M: Aldosterone modifies
hemostasis via upregulation of the protein-C receptor in human
vascular endothelium. Biochem Biophys Res Commun. 373:192–196.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rafii A, Mirshahi P, Poupot M, Faussat AM,
Simon A, Ducros E, Mery E, Couderc B, Lis R, Capdet J, Bergalet J,
Querleu D, Dagonnet F, Fournié JJ, Marie JP, Pujade-Lauraine E,
Favre G, Soria J and Mirshahi M: Oncologic trogocytosis of original
stromal cells induces chemoresistance of ovarian tumours. PLoS One.
3:e38942008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng T, Liu D, Griffin JH, Fernández JA,
Castellino F, Rosen ED, Fukudome K and Zlokovic BV: Activated
protein C blocks p53-mediated apoptosis in ischemic human brain
endothelium and is neuroprotective. Nat Med. 9:338–342. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mosnier LO, Zlokovic BV and Griffin JH:
The cytoprotective protein C pathway. Blood. 109:3161–3172. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suzuki K and Hayashi T: Protein C and its
inhibitor in malignancy. Semin Thromb Hemost. 33:667–672. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Uchiba M, Okajima K, Oike Y, Ito Y,
Fukudome K, Isobe H and Suda T: Activated protein C induces
endothelial cell proliferation by mitogen-activated protein kinase
activation in vitro and angiogenesis in vivo. Circ Res. 95:34–41.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kobayashi H, Moniwa N, Gotoh J, Sugimura M
and Terao T: Role of activated protein C in facilitating basement
membrane invasion by tumor cells. Cancer Res. 54:261–267.
1994.PubMed/NCBI
|
|
24
|
Uitte de Willige S, Van Marion V,
Rosendaal FR, Vos HL, de Visser MC and Bertina RM: Haplotypes of
the EPCR gene, plasma sEPCR levels and the risk of deep venous
thrombosis. J Thromb Haemost. 2:1305–1310. 2004.PubMed/NCBI
|
